Tubulis: Funding, Investors & Team (Sep 2026)
Tubulis creates specialized chemotherapy drugs that target cancer and chronic illnesses by combining unique technology with disease-specific biological knowledge. This allows medical professionals to treat cancer patients with fewer side effects than traditional chemotherapy.
Tubulis has raised $572M across 4 funding rounds on record, the most recent a Series C of $358M announced in Oct 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Tubulis Company Profile and Key Stats
Latest funding round on record: Oct 2025.
Tubulis Funding Rounds
Tubulis raised $10.7M in an undisclosed round announced in Jul 2020.
1.8 years later, a Series B of $63.2M was announced in May 2022.
1.8 years later, an undisclosed round of $140M was announced in Mar 2024.
1.6 years later, a Series C of $358M was announced in Oct 2025.
Tubulis Founders and Leadership Team
Contact details for the Tubulis team: 2 of 2 have an email address on file.
Start 14-day free trial →Tubulis Funding Compared to Other Biotechnology Startups
Tubulis' latest round of $358M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Tubulis in Biotechnology and Munich
Companies Similar to Tubulis
Computomics applies AI to bioinformatics data to enable rapid understanding of genomics and drive advanced…
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug…
Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of…
NanoStruct is a biotechnology company that develops nanostructured sensor chips to identify bacteria and…
Tacalyx, a company originating from Max-Planck-Institute of Colloids and Interfaces in Potsdam, Germany, is…
Primogene is a biotechnology company that provides ingredient development, bioprocess manufacturing, and…
Mbiomics is a company in the field of biotechnology.
At EVANIUM, we make plant compounds like polyphenols and flavonoids more effective by improving their…
Picea Biosolutions is a biotechnology firm. Based on their core platform technology, they develop tailored…
KUPANDO is a pioneering biopharmaceutical firm that is developing TLR 4/7 agonists to boost innate immunity.…
Tubulis Funding FAQs
What does Tubulis do?
Tubulis creates specialized chemotherapy drugs that target cancer and chronic illnesses by combining unique technology with disease-specific biological knowledge. This allows medical professionals to treat cancer patients with fewer side effects than traditional chemotherapy.
How much funding has Tubulis raised?
Tubulis has raised $572M across 4 rounds on record. The most recent is a Series C of $358M announced in Oct 2025.
When did Tubulis last raise funding?
Tubulis' most recent funding round on record is a Series C of $358M, announced in Oct 2025.
Who founded Tubulis?
FundedIQ lists Jonas Helma (Founder) at Tubulis.
Who is the CEO of Tubulis?
Dominik Schumacher is listed as CEO at Tubulis.
Where is Tubulis headquartered?
Tubulis is based in Munich, Bayern, Germany.
How many employees does Tubulis have?
Tubulis is in the 11-50 employee band.
How does Tubulis' funding compare to other Biotechnology startups?
Tubulis' latest round of $358M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Tubulis Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Tubulis is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.